课题基金 / 基金详情

CARRIER TESTING IN FRAGILE X SYNDROME: BIOETHICS

CARRIER TESTING IN FRAGILE X SYNDROME: BIOETHICS
脆性 X 综合征的携带者测试:生物伦理学
批准号:
6121789
负责人:
ALLYN MCCONKIE-ROSELLE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 1999-08-31

项目摘要

项目成果

ALLYN MCCONKIE-ROSELLE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Investigators and clinicians at the Fragile X Clinic at Duke University Medical Center have observed the variable response to carrier testing of women of diverse ages, as well as the direct impact upon them and upon their immediate and extended families. In a recently completed pilot study of obligate carriers of Fragile X Syndrome, which attempted to ascertain opinions and attitudes regarding carrier testing, 89% of the respondents reported that prior knowledge of carrier status would have changed their reproductive plans. The study also solicited the opinion of respondents as to optimal timing of carrier testing and the optimal age to inform children of the heritable nature of the Fragile X Syndrome. The present study is designed to examine whether (1) the outcome of carrier testing is correlated with changes in self-concept, coping behavior, and family adaptation and support, (2) whether such variables as family adaptation and support, or self concept, can be used to help predict an individual's response to the outcome of carrier testing, and (3) whether women who are at risk differ from obligate carriers in their assessments of optimal age for learning of the heritable nature of Fragile X Syndrome, and for undergoing carrier testing. Specific problems encountered with carrier testing may well be more related to life stages than to chronological age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CARRIER TESTING IN FRAGILE X SYNDROME
  • 批准号:
    6252898
  • 项目类别:
  • 资助金额:
    $1.42万
  • 财政年份:
    1997
  • 负责人:
    ALLYN MCCONKIE-ROSELLE
  • 依托单位:
CARRIER TESTING IN FRAGILE X SYNDROME
  • 批准号:
    5224667
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ALLYN MCCONKIE-ROSELLE
  • 依托单位:
    --
海外基金